China Resources Pharmaceutical Group Ltd.
3320.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$27.52B
Close$
Share Statistics
| Market cap | $27.52 Billion |
|---|---|
| Enterprise Value | $113.93 Billion |
| Dividend Yield | $0.22 (5.47%) |
| Earnings per Share | $0.72 |
| Beta | -0.4 |
| Outstanding Shares | 6,282,510,000 |
Return
| Return on Equity | 12.71% |
|---|---|
| Return on Assets | 2.28% |
| Return on Invested Capital | 15.21% |
Valuation & Multiples
| P/E Ratio | 5.84 |
|---|---|
| PEG | 61.4 |
| Price to Sales | 0.05 |
| Price to Book Ratio | 0.21 |
| Enterprise Value to Revenue | 0.19 |
| Enterprise Value to EBIT | 4.4 |
| Enterprise Value to Net Income | 14 |
| Total Debt to Enterprise | 1.03 |
| Debt to Equity | 1.93 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 24, 2026
EPS Estimate
$0.46
Average shareholder expectationRevenue Estimate
$159.99 B
Average shareholder expectationNext Earnings Call
Expected Date
March 24, 2027
EPS Estimate
$0.34
Average shareholder expectationRevenue Estimate
$163.81 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About China Resources Pharmaceutical Group Ltd.
84,000 employees
CEO: Xiaosong Bai China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through ...